Verity Pharmaceuticals

CompanyCanadaFounded 2022

Verity Pharmaceuticals develops 2 assets, the furthest approved (testosterone in hormone deficiency). Mostly small molecule acting on AR and lipid and ceramide metabolism; based in Canada, founded in 2022.

2
Assets
Furthest stage
Approved
0
Trials
21
Signals

Pipeline

2
  • testosterone

    Oral testosterone replacement therapy acting as an androgen receptor agonist.

    Approved, Small molecule, Lipid and ceramide metabolism, AR, hormone deficiency, hypoactive sexual desire disorder, Partner

  • TLANDO

    Oral testosterone undecanoate formulation providing testosterone replacement therapy.

    Approved, Small molecule, AR, hypogonadism, Partner

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms3
  • Signals20
  • Similar companies6

Intelligence